(Q45961690)

18 December 2017

title

Traditional Chinese medicine, a solution for reducing dual stroke risk factors at once? (English)

1 reference

18 December 2017

traditional Chinese medicine

main subject

1 reference

object named as

traditional Chinese medicine

17 February 2024

Kuan-Chung Chen

1

1 reference

18 December 2017

Kai-Wei Chang

series ordinal

2

1 reference

18 December 2017

Hsin-Yi Chen

series ordinal

3

1 reference

18 December 2017

Calvin Yu-Chian Chen

series ordinal

4

1 reference

18 December 2017

publication date

28 July 2011

1 reference

18 December 2017

published in

Molecular BioSystems

1 reference

18 December 2017

volume

7

1 reference

18 December 2017

issue

9

1 reference

18 December 2017

page(s)

2711-2719

1 reference

18 December 2017

Community participation following cerebrovascular accident: impact of the buffering model of social support

cites work

1 reference

https://api.crossref.org/works/10.1039%2FC1MB05164D

Update on genetics of stroke and cerebrovascular disease 2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1MB05164D

The gene encoding phosphodiesterase 4D confers risk of ischemic stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1MB05164D

Leukotriene B4: early mediator of atherosclerosis in obstructive sleep apnoea?

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1MB05164D

Key features for designing phosphodiesterase-5 inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1MB05164D

A novel strategy for designing the selective PPAR agonist by the "sum of activity" model

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1MB05164D

Structure-based and ligand-based drug design for HER 2 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1MB05164D

Insights into designing the dual-targeted HER2/HSP90 inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1MB05164D

Virtual screening and drug design for PDE-5 receptor from traditional Chinese medicine database

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1MB05164D

Computational screening and design of traditional Chinese medicine (TCM) to block phosphodiesterase-5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1MB05164D

TCM Database@Taiwan: the world's largest traditional Chinese medicine database for drug screening in silico

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1MB05164D

ADMET in silico modelling: towards prediction paradise?

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1MB05164D

Design of phosphodiesterase 4D (PDE4D) allosteric modulators for enhancing cognition with improved safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1MB05164D

Crystal structure of inhibitor-bound human 5-lipoxygenase-activating protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1MB05164D

5-Lipoxygenase-activating protein inhibitors. Part 2: 3-{5-((S)-1-Acetyl-2,3-dihydro-1H-indol-2-ylmethoxy)-3-tert-butylsulfanyl-1-[4-(5-methoxy-pyrimidin-2-yl)-benzyl]-1H-indol-2-yl}-2,2-dimethyl-propionic acid (AM679)--a potent FLAP inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1MB05164D

A family of phosphodiesterase inhibitors discovered by cocrystallography and scaffold-based drug design

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1MB05164D

Discovery of selective PDE4B inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1MB05164D

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1MB05164D

LigandFit: a novel method for the shape-directed rapid docking of ligands to protein active sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1MB05164D

CHARMM: the biomolecular simulation program

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1MB05164D

Discovery of a substituted 8-arylquinoline series of PDE4 inhibitors: structure-activity relationship, optimization, and identification of a highly potent, well tolerated, PDE4 inhibitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1MB05164D

Comparison of MLR, PLS and GA-MLR in QSAR analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1MB05164D

Application of Genetic Function Approximation to Quantitative Structure-Activity Relationships and Quantitative Structure-Property Relationships

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1MB05164D

Substituted 2,2-bisaryl-bicycloheptanes as novel and potent inhibitors of 5-lipoxygenase activating protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1MB05164D

5-lipoxygenase-activating protein inhibitors: development of 3-[3-tert-butylsulfanyl-1-[4-(6-methoxy-pyridin-3-yl)-benzyl]-5-(pyridin-2-ylmethoxy)-1H-indol-2-yl]-2,2-dimethyl-propionic acid (AM103).

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1MB05164D

21 January 2018

Identifiers

DOI

10.1039/C1MB05164D

1 reference

18 December 2017

1 reference

18 December 2017